Amarantus Bioscience Holdings Inc (AMBS)

[sante1]

I gonna believe more and more that Gerald's statement gonna come true, is no fairy-tail but uplisting becomes more and more a reality in the foreseable future without a R/S.
Eltropazine P2. Lympro bloodtest brought to the Market next year.

Perhaps even at $5,00 if a big Pharma shows interest.

I quote "Regenerative medicine space is “HOT” and attractive to Big Pharma –entry by acquisition". Unquote.